Radioprotection of the Intestinal Crypts of Mice by Recombinant Human Interleukin-1 Alpha
Overview
Authors
Affiliations
Recombinant human interleukin-1 alpha (rHIL-1 alpha or IL-1) protected the intestinal crypt cells of mice against X-ray-induced damage. The survival of crypt cells measured in terms of their ability to form colonies of regenerating duodenal epithelium in situ was increased when IL-1 was given either before or after irradiation. The maximum degree of radioprotection was seen when the drug was given between 13 and 25 h before irradiation. The IL-1 dose producing maximum protection was about 6.3 micrograms/kg. This is the first report indicating that the cytokine IL-1 has a radioprotective effect in the intestine. The finding suggests that IL-1 may be of potential value in preventing radiation injury to the gut in the clinic.
Vasin M Springerplus. 2014; 3:414.
PMID: 25133093 PMC: 4132458. DOI: 10.1186/2193-1801-3-414.
Staley E, Yarbrough V, Schoeb T, Daft J, Tanner S, Steverson Jr D Radiat Res. 2012; 178(3):207-16.
PMID: 22780103 PMC: 3474324. DOI: 10.1667/rr2835.1.
Umar S Curr Gastroenterol Rep. 2010; 12(5):340-8.
PMID: 20683682 PMC: 2965634. DOI: 10.1007/s11894-010-0130-3.
Kim K, McBride W Curr Drug Targets. 2010; 11(11):1352-65.
PMID: 20583981 PMC: 3079263. DOI: 10.2174/1389450111009011352.
Vidrich A, Buzan J, Barnes S, Reuter B, Skaar K, Ilo C Am J Pathol. 2005; 166(4):1055-67.
PMID: 15793286 PMC: 1602382. DOI: 10.1016/S0002-9440(10)62326-7.